Gefitinib 250 Mg Tab is a medication used in the treatment of certain types of cancer, particularly non-small cell lung cancer (NSCLC) that has specific genetic mutations. This is considered a targeted therapy because it specifically targets cancer cells with EGFR mutations while sparing normal cells, which can reduce the risk of certain side effects, associated with traditional chemotherapy. It is a targeted therapy drug that works by inhibiting the activity of a protein called epidermal growth factor receptor (EGFR), which plays a role in the growth and spread of cancer cells. Gefitinib 250 Mg Tab should be swallowed whole with a full glass of water, and it's essential not to crush, chew, or break them.
Specification
Brand |
Geftib |
Dose/Strength |
250 mg |
Manufacturer |
Natco Pharma Ltd |
Packaging Size |
1*10 Tablets |
Packaging Type |
Box |
Shelf Life |
24 month |
Usage/Application |
Hospital |